BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

699 related articles for article (PubMed ID: 20723761)

  • 1. Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress.
    Seifert U; Bialy LP; Ebstein F; Bech-Otschir D; Voigt A; Schröter F; Prozorovski T; Lange N; Steffen J; Rieger M; Kuckelkorn U; Aktas O; Kloetzel PM; Krüger E
    Cell; 2010 Aug; 142(4):613-24. PubMed ID: 20723761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-gamma, the functional plasticity of the ubiquitin-proteasome system, and MHC class I antigen processing.
    Strehl B; Seifert U; Krüger E; Heink S; Kuckelkorn U; Kloetzel PM
    Immunol Rev; 2005 Oct; 207():19-30. PubMed ID: 16181324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoproteasomes at the interface of innate and adaptive immune responses: two faces of one enzyme.
    Krüger E; Kloetzel PM
    Curr Opin Immunol; 2012 Feb; 24(1):77-83. PubMed ID: 22296715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC-encoded proteasome subunits LMP2 and LMP7 are not required for efficient antigen presentation.
    Yewdell J; Lapham C; Bacik I; Spies T; Bennink J
    J Immunol; 1994 Feb; 152(3):1163-70. PubMed ID: 8301122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diversity of proteasomal missions: fine tuning of the immune response.
    Borissenko L; Groll M
    Biol Chem; 2007 Sep; 388(9):947-55. PubMed ID: 17696779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remodelling of the ubiquitin-proteasome system in response to interferons.
    Seifert U; Krüger E
    Biochem Soc Trans; 2008 Oct; 36(Pt 5):879-84. PubMed ID: 18793155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes.
    Gaczynska M; Rock KL; Goldberg AL
    Nature; 1993 Sep; 365(6443):264-7. PubMed ID: 8396732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel dipeptide aldehydes are proteasome inhibitors and block the MHC-I antigen-processing pathway.
    Harding CV; France J; Song R; Farah JM; Chatterjee S; Iqbal M; Siman R
    J Immunol; 1995 Aug; 155(4):1767-75. PubMed ID: 7636233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of CYP2E1-dependent oxidant stress on activity of proteasomes in HepG2 cells.
    Kessova IG; Cederbaum AI
    J Pharmacol Exp Ther; 2005 Oct; 315(1):304-12. PubMed ID: 16002458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation of proteasomal degradation of biosynthesized viral proteins from generation of MHC class I-associated antigenic peptides.
    Antón LC; Snyder HL; Bennink JR; Vinitsky A; Orlowski M; Porgador A; Yewdell JW
    J Immunol; 1998 May; 160(10):4859-68. PubMed ID: 9590233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of proteasome-mediated protein degradation during oxidative stress and aging.
    Breusing N; Grune T
    Biol Chem; 2008 Mar; 389(3):203-9. PubMed ID: 18208355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal IFN-gamma-dependent immunoproteasome modulation by Trypanosoma cruzi-infected macrophages.
    Bergeron M; Blanchette J; Rouleau P; Olivier M
    Parasite Immunol; 2008 May; 30(5):280-92. PubMed ID: 18312504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteasome activity limits the assembly of MHC class I molecules after IFN-gamma stimulation.
    Benham AM; Neefjes JJ
    J Immunol; 1997 Dec; 159(12):5896-904. PubMed ID: 9550386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective involvement of proteasomes and cysteine proteases in MHC class I antigen presentation.
    López D; Del Val M
    J Immunol; 1997 Dec; 159(12):5769-72. PubMed ID: 9550370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of in silico predicted coxsackievirus B3-derived MHC class I epitopes by proteasomes.
    Voigt A; Jäkel S; Textoris-Taube K; Keller C; Drung I; Szalay G; Klingel K; Henklein P; Stangl K; Kloetzel PM; Kuckelkorn U
    Amino Acids; 2010 Jun; 39(1):243-55. PubMed ID: 19997756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rate of antigen degradation by the ubiquitin-proteasome pathway influences MHC class I presentation.
    Grant EP; Michalek MT; Goldberg AL; Rock KL
    J Immunol; 1995 Oct; 155(8):3750-8. PubMed ID: 7561079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast cell-mediated antigen presentation regulates CD8+ T cell effector functions.
    Stelekati E; Bahri R; D'Orlando O; Orinska Z; Mittrücker HW; Langenhaun R; Glatzel M; Bollinger A; Paus R; Bulfone-Paus S
    Immunity; 2009 Oct; 31(4):665-76. PubMed ID: 19818652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual inhibition of proteasomal and lysosomal proteolysis ameliorates autoimmune central nervous system inflammation.
    Fissolo N; Kraus M; Reich M; Ayturan M; Overkleeft H; Driessen C; Weissert R
    Eur J Immunol; 2008 Sep; 38(9):2401-11. PubMed ID: 18792018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The components of the proteasome system and their role in MHC class I antigen processing.
    Krüger E; Kuckelkorn U; Sijts A; Kloetzel PM
    Rev Physiol Biochem Pharmacol; 2003; 148():81-104. PubMed ID: 12687403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.